Randall Schatzman
Corporate Officer/Principal at AlderBio Holdings LLC
Net worth: 12 016 $ as of 30/04/2024
Randall Schatzman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AlderBio Holdings LLC | Corporate Officer/Principal | - | - |
Career history of Randall Schatzman
Former positions of Randall Schatzman
| Companies | Position | Start | End |
|---|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Director/Board Member | 01/07/2019 | 15/05/2024 |
| Chief Executive Officer | 01/07/2019 | 15/05/2024 | |
| ALDER BIOPHARMACEUTICALS, INC. | Director/Board Member | 21/01/2013 | 20/03/2018 |
| Chief Executive Officer | 01/01/2004 | 20/03/2018 | |
| Founder | 01/01/2004 | 20/03/2018 | |
| Investor Relations Contact | 01/01/2004 | - | |
| President | 01/01/2004 | 20/03/2018 | |
Mercator Genetics, Inc.
 Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Progenitor, Inc., Mercator Genetics, Inc. develops gene therapy programs for asthma, schizophrenia, and cancer. The company is based in Menlo Park, CA. Mercator Genetics was acquired by Progenitor, Inc. on February 18, 1997 for $22 million. | Corporate Officer/Principal | 01/01/1995 | 01/01/1999 |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
Celltech R&D, Inc.
 Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA. | Corporate Officer/Principal | - | - |
Training of Randall Schatzman
| Emory University | Doctorate Degree |
| Purdue University | Undergraduate Degree |
Statistics
International
| United States | 8 |
| Canada | 3 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Mercator Genetics, Inc.
Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Progenitor, Inc., Mercator Genetics, Inc. develops gene therapy programs for asthma, schizophrenia, and cancer. The company is based in Menlo Park, CA. Mercator Genetics was acquired by Progenitor, Inc. on February 18, 1997 for $22 million. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Celltech R&D, Inc.
Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA. | Retail Trade |
| Syntex, Inc. | Miscellaneous |
| AlderBio Holdings LLC | |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Randall Schatzman
- Experience
